Delivery Order SPE2DB24D2205-SPE2DB24FDYUD

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens. The contract has a firm fixed price of $2,265.90 and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) auto-injector pens. The contract has a ceiling value of $7,144.68 and an ultimate completion date of November 24, 2023. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of Humira (adalimumab) 40 mg/0.4 mL autoinjector pens. The $11,082.96 contract is a firm fixed-price order with an ultimate completion date of August 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to provide a wide range of essential...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,127.20 firm-fixed-price contract is for the delivery of Humira Pen 40mg/0.4mL autoinjectors, a biologic medication used to treat various inflammatory conditions. The contract has an ultimate completion date of June 12, 2025. AmerisourceBergen also holds a $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens. The contract is a firm fixed-price delivery order with a ceiling value of $3,148.60 and a period of performance through April 18, 2025. This contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) auto-injector pens, a biologic medication used to treat various autoimmune conditions. The contract has a firm fixed price of $1,014.65 and a period of performance through April 18, 2025. It is not designated as a set-aside contract, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) autoinjector pens. The award, a Delivery Order valued at $42,560.00, has a firm fixed price and is not set aside for any specific business category. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen, through its Corporate Office division, will deliver the Humira pens to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) auto-injector pens. The contract has a ceiling value of $36,256.81 and runs through May 23, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Humira (adalimumab) auto-injector pens. The contract has a firm fixed price of $5,578.41 and a completion date of September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this contract to provide the Humira drug product to the DLA, which supports the healthcare needs of military personnel, veterans, and other federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for the supply of Humira (adalimumab) auto-injector pens. The contract is a firm-fixed price delivery order with a ceiling value of $1,847.20 and a period of performance through August 27, 2024. There is no set-aside designation for this award. Amerisourcebergen has a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDYUD
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Humira (adalimumab) 40 mg/0.4 mL autoinjector pens. The $5,488.68 firm fixed-price contract has an ultimate completion date of August 21, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts to provide a wide range of prescription medications, medical supplies, and equipment to various government agencies and healthcare programs, including the Department of Defense. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, to efficiently deliver essential pharmaceutical and medical products to military treatment facilities, veterans' hospitals, and other federal healthcare providers.

Generated 11/19/24, 9:33 AM